Impact of prior oral anticoagulant use and outcomes on patients from secondary analysis in the AUGUSTUS trial

OBJECTIVE: Managing antithrombotic therapy in patients with atrial fibrillation (AF) and an acute coronary syndrome (ACS) and/or percutaneous coronary intervention (PCI) is challenging and can be affected by prior oral anticoagulant (OAC) treatment. We examined the relationship between prior OAC use...

Descripción completa

Detalles Bibliográficos
Autores principales: Welsh, Robert C., Dehghani, Payam, Lopes, Renato, Wojdyla, Daniel M, Aronson, Ronald, Granger, Christopher B, Windecker, Stephan, Vora, Amit N, Vinereanu, Dragos, Halvorsen, Sigrun, Parkhomenko, Alexander, Mehran, Roxana, Alexander, John H, Goodman, Shaun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Coronary Artery Disease
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8852719/
https://www.ncbi.nlm.nih.gov/pubmed/35172988
http://dx.doi.org/10.1136/openhrt-2021-001892

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8852719/
https://www.ncbi.nlm.nih.gov/pubmed/35172988
http://dx.doi.org/10.1136/openhrt-2021-001892

Ejemplares similares